JMP Securities Downgrades Achillion Pharmaceuticals (ACHN) to Market Perform Following Acquisition Offer Nov 7, 2019 12:40PM
Achillion Pharmaceuticals (ACHN) PT Raised to $11 at JMP Securities Aug 8, 2019 03:00PM
Achillion to Present at the JMP Securities Life Sciences Conference Jun 13, 2019 07:00AM
Achillion to Present at the 2018 JMP Securities Life Sciences Conference Jun 14, 2018 06:05AM
Achillion to Present at the 2017 JMP Securities Life Sciences Conference Jun 15, 2017 04:05PM


Jul 7, 2016 10:47AM Notable Analyst Rating Changes 7/7: (GLW) (ACHN) (MRO) Upgraded; (CHNI) (DEPO) (YUME) Downgraded
Jul 7, 2016 06:36AM JMP Securities Upgrades Achillion Pharmaceuticals (ACHN) to Market Outperform
Jun 1, 2016 04:02PM Achillion to Present at Three Upcoming Investor Conferences
Jun 18, 2015 06:05AM Achillion to Present at the JMP Securities Life Sciences Conference 2015
May 20, 2015 06:32AM JMP Securities Downgrades Achillion Pharmaceuticals (ACHN) to Market Perform
Feb 12, 2015 06:38AM Achillion Pharma (ACHN) 12M Offering Prices at $10.25/Share
Jun 10, 2014 06:42AM JMP Securities Upgrades Achillion Pharmaceuticals (ACHN) to Market Outperform
Mar 24, 2014 09:32AM Pre-Open Stock Movers 3/24: (NUS) (MVIS) (HLF) Higher; (NBR) (NTAP) (WLT) Lower (more...)
Sep 30, 2013 06:44AM JMP Securities Downgrades Achillion Pharmaceuticals (ACHN) to Market Perform
Feb 22, 2013 06:41AM Achillion Pharmaceuticals (ACHN) Prices 15M Shares at $8.40
Sep 19, 2012 10:49AM Notable Analyst Rating Changes 09/19: (ACHN) (GLW) (AZN) Upgraded; (IDIX) (WM) (SCHW) Downgraded
Aug 16, 2012 11:04AM Notable Analyst Rating Changes 08/16: (NWE) (KMI) (ACHN) Upgraded; (AMAT) (SPLS) (ANF) Downgraded
Aug 16, 2012 07:11AM JMP Securities Upgrades Achillion Pharmaceuticals (ACHN) to Market Outperform
Apr 23, 2012 08:08AM JMP Securities Downgrades Achillion Pharmaceuticals (ACHN) to Market Perform
Feb 17, 2012 11:58AM JMP Securities Upgrades Achillion Pharmaceuticals (ACHN) to Market Outperform
Jan 9, 2012 03:24PM JMP Cuts Idenix (IDIX) to Market Underperform, Sets $4 Price Target
Aug 7, 2009 08:12AM JMP Securities Upgrades Achillion Pharmaceuticals (ACHN) to Market Perform